 |
| Kidney Transplant Market |
The kidney transplant market is a crucial component of the healthcare industry. Kidney transplantation involves surgically placing a healthy kidney from a living or deceased donor into a patient whose kidneys have failed. It is primarily used as a treatment for end-stage kidney failure or kidney failure. Kidney transplantation is usually an option when dialysis can no longer sufficiently support a patient's health.
The global kidney transplant market is
estimated to be valued at US$ 99232.33 Bn in 2024 and is expected to exhibit a
CAGR of 11% over the forecast period from 2024 to 20301.
Kidney
transplantation procedures involve harvesting a healthy kidney from a deceased
or living donor and implanting it into a patient whose kidneys have failed.
These procedures help improve the quality of life for patients with end-stage
renal disease who are otherwise dependent on regular dialysis treatments.
Advancements in surgical techniques, immunosuppressive drugs, and organ
preservation methods have made kidney transplantation a viable treatment
option.
Key Takeaways
Key players operating in the kidney transplant market are Alumasc Group Plc,
Binderholz GmbH, Bauder Ltd, Forbo International SA, Certain Teed Corporation,
The Turner Corp, Clark Group, Gilbane Building Co, Hensel Phelps, and The
Whiting-Turner Contracting Co.
The rising incidence of chronic kidney diseases (CKD) due to diabetes,
hypertension, vascular diseases, and glomerulonephritis is expected to offer
lucrative growth opportunities for players in the Kidney
Transplant Market Demand According to data by the National Kidney
Foundation, over 90,000 Americans are currently on the kidney transplant
waiting list with more being added daily due to the shortage of organ donors.
The increasing efforts made by regional governments and transplant centers to
spread awareness about organ donation among citizens and modern transplant
technologies adoption are driving the international expansion of major kidney
transplant market players. Some key markets like US, China, and European
countries are focusing on self-sufficiency in organ transplantation through
deceased and living donor programs.
Market Drivers
The rising prevalence of end-stage renal disease (ESRD) due to diabetes,
hypertension, and other chronic conditions has been a key driver of the kidney
transplant market growth. In many developed nations, ESRD cases have grown to
become a major health burden. For example, the Centers for Disease Control and
Prevention (CDC) estimates that over 750,000 Americans currently have ESRD.
Market Restraints
Lack of organ donors remains one of the major challenges faced by the kidney
transplant market. Unlike liver and heart transplants, kidney transplantation
relies solely on living or deceased organ donors. Long donor organ shortage
lists and waiting times of 3 to 5 years for suitable kidneys limits timely
access to this life-saving treatment option. Many patients succumb to kidney
failure while awaiting transplantation. Cultural and ethical barriers in some
countries to organ donation further compound the issue.
Segment Analysis
Kidney transplantation is one of the key segments in the Kidney Transplant
Market. Kidney transplantation from living donors dominates this segment
currently, accounting for over 60% of the total kidney transplants performed
globally. This is primarily due to better outcomes and increased organ availability
compared to deceased donor kidney transplantation. However, demand for deceased
donor kidney transplantation is growing at a faster rate due to rise in organ
failure cases and lack of living donors.
Global Analysis
North America region currently dominates the global Kidney Transplant Market
accounting for over 40% of the total market share. This is due to presence of
excellent healthcare infrastructure and high adoption of advanced transplant
procedures in countries like US and Canada. Asia Pacific is projected to be the
fastest growing market during the forecast period owing to large patient pool,
increasing awareness about organ donation and transplantation, and rising
healthcare spending in countries like China and India.
0 Comments